Access cutting-edge chronic graft versus host disease treatment through this clinical trial at a research site in Valhalla. Study-provided care at no cost to qualified participants.
Access chronic graft versus host disease specialists in Valhalla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic graft versus host disease treatment provided free
The purpose of this study is to measure safety and efficacy of oral belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander male and female participants with cGVHD who have previously been treated with at least 2 prior lines of systemic therapy aged 12 years and above. The duration of participants participation will be up to 4 weeks for screening, treatment until clinically significant progression of disease, and 4 weeks of safet
Sponsor: Kadmon, a Sanofi Company
Check if you qualify for this chronic graft versus host disease clinical trial in Valhalla, NY
If you're searching for chronic graft versus host disease treatment options in Valhalla, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Valhalla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic graft versus host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.